Loading clinical trials...

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent | Clinical Trials | Clareo Health

TERMINATED

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Long-Term Follow-Up of Selected Patients Enrolled in Phase 3 Clinical Trial 127-014 Using PB127 Ultrasound Imaging Agent

NCT00584714•Point Biomedical

View on ClinicalTrials.gov

Summary

The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients enrolled in Protocol 127-014 who
•1. Were enrolled in Stratum 1
•2. Did not undergo angiography during study evaluation
•3. Did not have a clinical oucome during the initial 6 month follow-up period as described in Protocol 127-014.

Locations (39)

University of Arizona Saver Heart Clinic

Tucson, Arizona, United States

Cardiovascular Associates of the Peninsula

Burlingame, California, United States

Long Beach VA Medical Center Cardiology Division

Long Beach, California, United States

Cedars Sinai Medical Center Division of Cardiology

Los Angeles, California, United States

Sutter Roseville Medical Center

Roseville, California, United States

University of California San Diego Division of Cardiology

San Diego, California, United States

San Francisco VA Medical Center NCIRE

San Francisco, California, United States

Connecticut Clinical Research

Bridgeport, Connecticut, United States

Alfieri Cardiology

Newark, Delaware, United States

Washington Hospital Center Cardiovascular Research Institute

Washington D.C., District of Columbia, United States

Key Dates

Start Date

October 1, 2007

Primary Completion Date

July 1, 2008

Completion Date

July 1, 2008

Last Updated

July 3, 2008

Enrollment

300

ESTIMATED participants

Conditions

Coronary Artery Disease

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 3, 2008Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

Inclusion Criteria

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

"Erectile Function After PCI in MI and Non-MI Patients"

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Product Surveillance Registry

Essential Pro Study ( rEPIC04E-HK )

Factors Affect Outcomes in Cardiovascular Surgery